VIENNALAB - Established innovations in diagnostics
The BRAF gene is mutated in approximately 8% of human tumors, mostly melanoma, colorectal and thyroid cancers. The BRAF StripAssay® rapidly identifies the most relevant mutation in the BRAF gene.
The BRAF gene is mutated in approximately 8% of human tumors, mostly melanoma, colorectal and thyroid cancers.
The BRAF StripAssay® rapidly identifies the most relevant mutation in the BRAF gene.
BRAF Mutations
- BRAF encodes a serine/threonine protein kinase which plays a role in signalling pathways involved in cell proliferation and differentiation.
- Some BRAF mutations significantly increase the BRAF gene product leading to neoplastic growth.
- Identification of BRAF genetic variants is thus the key to the best therapy for melanoma and thyroid cancer.
Product Details
| BRAF StripAssay® |  | 5-570 |